Genomics and Pharmacogenomics in Anticancer Drug Development and Clinical Response
Latest Publications

TOTAL DOCUMENTS

21

(FIVE YEARS 0)

H-INDEX

1

(FIVE YEARS 0)

Published By Humana Press

9781588296467, 9781603270885

Latest Documents Most Cited Documents Contributed Authors Related Sources Related Keywords

Concordance Between Tumor and Germline DNA

Genomics and Pharmacogenomics in Anticancer Drug Development and Clinical Response ◽

10.1007/978-1-60327-088-5_7 ◽

2008 ◽

pp. 91-101 ◽

Author(s):

Sharon Marsh

Download Full-text

MicroRNAs and Discovery of New Targets

Genomics and Pharmacogenomics in Anticancer Drug Development and Clinical Response ◽

10.1007/978-1-60327-088-5_4 ◽

2008 ◽

pp. 47-56

Author(s):

Soken Tsuchiya ◽

Yasushi Okuno ◽

Gozoh Tsujimoto

Keyword(s):

Download Full-text

Strategies to Identify Pharmacogenomic Biomarkers: Candidate Gene, Pathway-Based, and Genome-Wide Approaches

Genomics and Pharmacogenomics in Anticancer Drug Development and Clinical Response ◽

10.1007/978-1-60327-088-5_21 ◽

2008 ◽

pp. 353-370 ◽

Author(s):

Xifeng Wu ◽

Jian Gu ◽

Margaret R. Spitz

Keyword(s):

Candidate Gene ◽

Gene Pathway ◽

Download Full-text

DNA Repair and Mitotic Checkpoint Genes as Potential Predictors of Chemotherapy Response in Non-Small-Cell Lung Cancer

Genomics and Pharmacogenomics in Anticancer Drug Development and Clinical Response ◽

10.1007/978-1-60327-088-5_13 ◽

2008 ◽

pp. 231-247 ◽

Author(s):

Rafael Rosell ◽

Miquel Taron ◽

Mariacarmela Santarpia ◽

Fernanda Salazar ◽

Jose Luis Ramirez ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Mitotic Checkpoint ◽

Chemotherapy Response ◽

Small Cell Lung ◽

Checkpoint Genes

Download Full-text

Pharmacogenomics of the National Cancer Institute’s 60-Tumor Cell Panel

Genomics and Pharmacogenomics in Anticancer Drug Development and Clinical Response ◽

10.1007/978-1-60327-088-5_5 ◽

2008 ◽

pp. 57-74

Author(s):

Anders Wallqvist ◽

Ruili Huang ◽

David G. Covell

Keyword(s):

Download Full-text

Proteomic Analysis in Cancer Patients

Genomics and Pharmacogenomics in Anticancer Drug Development and Clinical Response ◽

10.1007/978-1-60327-088-5_3 ◽

2008 ◽

pp. 33-45 ◽

Author(s):

Yasuhiro Kuramitsu ◽

Kazuyuki Nakamura

Keyword(s):

Cancer Patients ◽

Proteomic Analysis

Download Full-text

Toxicogenomics Application to Oncology Drug Development

Genomics and Pharmacogenomics in Anticancer Drug Development and Clinical Response ◽

10.1007/978-1-60327-088-5_20 ◽

2008 ◽

pp. 339-351

Author(s):

Luigi Calzolai ◽

Teresa Lettieri

Keyword(s):

Drug Development ◽

Oncology Drug ◽

Oncology Drug Development

Download Full-text

Identification of Pharmacogenomic Biomarker Classifiers in Cancer Drug Development

Genomics and Pharmacogenomics in Anticancer Drug Development and Clinical Response ◽

10.1007/978-1-60327-088-5_19 ◽

2008 ◽

pp. 327-338

Author(s):

Richard Simon

Keyword(s):

Drug Development ◽

Download Full-text

Microarray Profiling in Breast Cancer Patients

Genomics and Pharmacogenomics in Anticancer Drug Development and Clinical Response ◽

10.1007/978-1-60327-088-5_16 ◽

2008 ◽

pp. 287-298

Author(s):

Yong Qian ◽

Xianglin Shi ◽

Vincent Castranova ◽

Nancy L. Guo

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Breast Cancer Patients ◽

Microarray Profiling

Download Full-text

BCR-ABL Mutations and Imatinib Resistance in Chronic Myeloid Leukemia Patients

Genomics and Pharmacogenomics in Anticancer Drug Development and Clinical Response ◽

10.1007/978-1-60327-088-5_9 ◽

2008 ◽

pp. 127-150

Author(s):

Mark R. Litzow

Keyword(s):

Chronic Myeloid Leukemia ◽

Myeloid Leukemia ◽

Imatinib Resistance

Download Full-text